HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aziz Nazha Selected Research

Hematopoietic Stem Cell Transplantation

11/2020A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aziz Nazha Research Topics

Disease

19Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021 - 08/2012
12Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2022 - 02/2015
9Neoplasms (Cancer)
01/2021 - 02/2015
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 05/2012
4Leukemia
11/2021 - 01/2017
3Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2022 - 02/2015
3Primary Myelofibrosis (Myelosclerosis)
09/2016 - 10/2015
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 11/2021
2Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 10/2015
2Thrombosis (Thrombus)
09/2016 - 04/2016
2Polycythemia Vera
09/2016 - 04/2016
1Chronic Brain Damage
04/2022
1Invasive Fungal Infections
04/2022
1Renal Insufficiency (Renal Failure)
04/2022
1Intracranial Hemorrhages (Intracranial Hemorrhage)
04/2022
1T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
01/2022
1COVID-19
08/2021
1Coronavirus Infections
08/2021
1Asthma (Bronchial Asthma)
01/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2019
1Thrombocytopenia (Thrombopenia)
01/2019
1Thyroid Neoplasms (Thyroid Cancer)
01/2018
1Anemia
01/2018
1Neutropenia
01/2018
1Splenomegaly
09/2016
1Multiple Myeloma
02/2015
1Hemorrhage
10/2013
1Down Syndrome (Down's Syndrome)
09/2013
1Hairy Cell Leukemia
02/2013

Drug/Important Bio-Agent (IBA)

4Biological ProductsIBA
12/2019 - 09/2013
4Tyrosine Kinase InhibitorsIBA
11/2013 - 05/2012
3Cytarabine (Cytosar-U)FDA LinkGeneric
10/2021 - 11/2013
3Azacitidine (5 Azacytidine)FDA Link
08/2017 - 06/2013
2LigandsIBA
11/2021 - 01/2021
2Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2019
2Mitoxantrone (Novantrone)FDA LinkGeneric
10/2021 - 01/2019
2Hydroxyurea (Hydrea)FDA LinkGeneric
09/2016 - 04/2016
1P-2 (P 2)IBA
04/2022
1Hemoglobins (Hemoglobin)IBA
11/2021
1Immunoglobulins (Immunoglobulin)IBA
11/2021
1alvocidib (flavopiridol)IBA
10/2021
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2021
1CXC ChemokinesIBA
01/2021
1GlucocorticoidsIBA
01/2021
1Lysine (L-Lysine)FDA Link
01/2020
1Histone Deacetylase InhibitorsIBA
01/2020
1SirtuinsIBA
01/2020
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2020
1IMP DehydrogenaseIBA
01/2020
1ixazomibIBA
01/2019
1Etoposide (VP 16)FDA LinkGeneric
01/2019
1IodineIBA
01/2018
1ON 01910IBA
12/2017
1VorinostatFDA Link
08/2017
1Lenalidomide (CC 5013)FDA Link
08/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1ruxolitinibIBA
09/2016
1Heterogeneous-Nuclear Ribonucleoprotein KIBA
10/2015
1CollagenIBA
10/2015
1Reticulin (Reticular Fiber)IBA
10/2015
1midostaurinIBA
04/2015
1MDS 11IBA
02/2015
1Clofarabine (Clolar)FDA Link
11/2013
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
11/2013
1NucleosidesIBA
11/2013
1InterferonsIBA
10/2013
1ponatinibIBA
10/2013
1HomoharringtonineIBA
10/2013
1NucleophosminIBA
08/2013
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2013
1Sorafenib (BAY 43-9006)FDA Link
06/2013
1Rituximab (Mabthera)FDA Link
02/2013
1purineIBA
02/2013
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2013
1fms-Like Tyrosine Kinase 3IBA
08/2012
1Tyrosine (L-Tyrosine)FDA Link
08/2012
1Imatinib Mesylate (Gleevec)FDA Link
05/2012

Therapy/Procedure

15Therapeutics
01/2021 - 10/2013
5Cell Transplantation
03/2022 - 01/2019
4Drug Therapy (Chemotherapy)
12/2019 - 01/2013
1Donor Selection
03/2022
1Homologous Transplantation
01/2022
1MDC protocol
01/2022
1Length of Stay
08/2021
1Ambulatory Care (Outpatient Care)
01/2021
1Hematopoietic Stem Cell Transplantation
11/2020
1Thyroidectomy
01/2018
1Precision Medicine
01/2017
1Complementary Therapies (Alternative Medicine)
04/2016
1Aftercare (After-Treatment)
02/2016
1Induction Chemotherapy
08/2012